Navigation Links
PeaceHealth Laboratories' New Patent Addresses a Leading Cause of Death: Prescription Drug Abuse
Date:5/30/2012

SPRINGFIELD, Ore., May 30, 2012 /PRNewswire/ -- PeaceHealth Laboratories today announced the national availability and receipt of a federal patent for PtProtect™ (Patient Protect), a pain medication monitoring program offering the industry's highest levels of accuracy to detect prescription pain medication and identify potential negative drug interactions before they occur. PtProtect directly addresses the safety and financial concerns of prescription pain medication abuse by using the most sensitive and definitive assays to detect medication and illicit drugs.

In the most recent review period January – April, 2012, PeaceHealth Laboratories found that 35 percent of PtProtect test results returned discrepant results outside a patient's known prescriptions. Because PtProtect identifies patients who are taking or potentially diverting prescribed pain medications, taking pain medications that are not prescribed to them, or using drugs of abuse it has the potential to significantly reduce accidental deaths. (1)

"PtProtect saves lives, saves practices and saves communities money," said Ran Whitehead, Chief Executive Officer of PeaceHealth Laboratories. "Now physicians may know, with confidence, what pain medications their patient is taking and prescribe accordingly to the highest levels of safety. This patent validates our rigorous science and practical application of this life-saving technology. It also enables providers to protect their practices from uncertain liabilities including malpractice and patient mortality."

In recognition of PtProtect's technology and capabilities, the U.S. Patent and Trademark Office issued U.S. Patent No. 8,067,243 granting exclusive rights to PtProtect™.  

About PtProtect

PtProtect is a patented testing program that detects up to 38 prescribed medications and illicit drugs. Medications are revealed at the industry's lowest thresholds for the most sensitive, comprehensive detection of opiates and opioids, thus reducing the possibility of adverse drug interactions. Simple and timely reporting allows doctors to quickly determine if test results are consistent or inconsistent with patient prescriptions.

PtProtect is available through PeaceHealth Laboratories and may be administered by physicians nationwide. For information about PtProtect, visit www.ptprotect.com or call 800-826-3616.

About PeaceHealth Laboratories

PeaceHealth Laboratories is a division of PeaceHealth, a not-for-profit health care system with a mission of promoting personal and community health since 1890. PeaceHealth Laboratories provides comprehensive laboratory services throughout the Pacific Northwest (Oregon, Washington and Alaska), and specialty testing for clinicians and employers across the U.S. With 9 laboratories and 27 patient service centers in three states, PeaceHealth Laboratories is one of the largest laboratory systems in the Pacific Northwest. Learn more at www.peacehealthlabs.org

(1) Source: CNNMoney February 24, 2012


'/>"/>
SOURCE PeaceHealth Laboratories
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. PeaceHealth Standardizes Hematology Operations With Sysmex
2. Daiichi Sankyo and Forest Laboratories Finalize Contract for Co-Promotion of AZOR(TM)
3. Forest Laboratories, Inc. and Gedeon Richter Announce Results of Phase II-B Study for RGH-188 as a Treatment for Schizophrenia
4. Forest Laboratories, Inc. Announces Positive Results of LEXAPRO(R) Phase III Study in Adolescents With Major Depression
5. Romark Laboratories Raises $18 Million in Institutional Financing
6. Microbia and Forest Laboratories Announce Preliminary Results of Linaclotide Phase 2b Studies
7. Romark Laboratories Initiates Phase II Study of Nitazoxanide in Treatment-Naive Patients With Chronic Hepatitis C Genotype 1
8. Northfield Laboratories Inc. Presentation at FDA/NIH Workshop on Hemoglobin-Based Oxygen Carriers
9. Ironwood Pharmaceuticals and Forest Laboratories Announce Presentation of Linaclotide Phase 2b Chronic Constipation Study Results
10. Romark Laboratories Completes Enrollment in U.S. Phase II Study of Nitazoxanide for Chronic Hepatitis C Genotype 1 Non-Responders
11. Forest Laboratories Announces Positive Results from Phase III Clinical Studies of Ceftaroline for the Treatment of Complicated Skin and Skin Structure Infections
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2020)... ... August 31, 2020 , ... Welltech1, the first ... they have invested $400,000 in PopBase, one of two start-ups that beat 152 ... Wellness Institute (GWI). , The competition was part of the GWI’s The ...
(Date:8/28/2020)... ... 2020 , ... Cano Health, LLC, a leading population health ... Antonio is happy to announce that it has selected Tejano musician Jay Perez ... will serve as community advisor, advertising talent, and creative consultant for Cano Health, ...
(Date:8/27/2020)... ... 2020 , ... Austin Oral Surgery – an oral and maxillofacial surgery practice ... DDS, MD, has joined the practice. An accomplished oral and maxillofacial surgeon, Dr. Szalay’s ... scheduled to open this fall. The new office is slated for 1601 E. Pflugerville ...
Breaking Medicine Technology:
(Date:8/31/2020)... ... August 31, 2020 , ... ... N95 face masks to medical first responders across the United States. Since the ... of personal protective equipment (PPE) medical centers , hospitals , ...
(Date:8/31/2020)... ... August 31, 2020 , ... ... solution for chiropractors, announced today the launch of its integrated, HIPAA compliant, telehealth ... running their virtual practice in under 90 seconds. , According to the ...
(Date:8/31/2020)... ... August 31, 2020 , ... ... to dental groups in the United States, today announced the grand opening of ... CA. , Patients will enjoy convenient hours, a comfortable office, and full-service ...
(Date:8/31/2020)... ... August 31, 2020 , ... A Cure for Covid-19 “PTS” with Mediation & Hypnosis ... are in a state of panic, experiencing deep anxiety, immense stress, and right now are ... is timely when most people on the planet are experiencing a great degree of emotional ...
(Date:8/31/2020)... ... 2020 , ... Dr. Chang has over 20 years of ... developmental disabilities, as well as supporting staff in caring for patients and families. ... and staff development. She joined the company in 2015 as Chief of Clinical ...
Breaking Medicine News(10 mins):